|本期目录/Table of Contents|

[1]谢醒文,杨振宁,葛鑫,等.脓毒症相关凝血功能障碍对脓毒症患者预后的评估价值[J].医学研究与战创伤救治(原医学研究生学报),2020,22(2):161-164.[doi:10.3969/j.issn.1672-271X.2020.02.011]
　XIE Xing wen,YANG Zhen ning,GE Xin,et al.A clinical research on relationship between sepsisassociated coagulopathy and prognosis in patients with sepsis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(2):161-164.[doi:10.3969/j.issn.1672-271X.2020.02.011]
点击复制

脓毒症相关凝血功能障碍对脓毒症患者预后的评估价值()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第22卷
期数:
2020年2期
页码:
161-164
栏目:
临床研究
出版日期:
2020-03-11

文章信息/Info

Title:
A clinical research on relationship between sepsisassociated coagulopathy and prognosis in patients with sepsis
作者:
谢醒文; 杨振宁; 葛鑫; 白小翠; 韩小琴
作者单位：210002南京，东部战区总医院(原南京军区南京总医院)急诊医学科（谢醒文、杨振宁、葛鑫、白小翠、韩小琴）
Author(s):
XIE Xingwen;  YANG Zhenning;  GE Xin;  BAI Xiaocui;  HAN Xiaoqin
（Department of Emergency Medicine，General Hospital of Eastern Theater Command, PLA, Nanjing 210002, Jiangsu，China）
关键词:
脓毒症; 凝血功能障碍; 急性生理与慢性健康Ⅱ评分; 中国弥散性血管内凝血诊断积分系统; 住院病死率; 预后; 秩相关
Keywords:
sepsis;  coagulopathy;  APACHE Ⅱ score;  Chinese DIC scoring system;  hospital mortality;  prognosis;  rank correlation
分类号:
R4
DOI:
10.3969/j.issn.1672-271X.2020.02.011
文献标志码:
A
摘要:
目的评价脓毒症相关凝血功能障碍（SAC）诊断标准预测脓毒症患者预后的价值。方法回顾性分析2014年6月至2017年6月入住东部战区总医院急诊重症监护病房（EICU）脓毒症患者的临床资料，根据入科时的国际标准化比值和血小板计数确定患者的SAC诊断，将患者分为无SAC、轻度SAC、中度SAC和重度SAC四组，记录各组患者入科时的年龄、性别、急性生理与慢性健康Ⅱ（APACHE Ⅱ）评分、中国弥散性血管内凝血诊断积分 (CDS)，基础疾病及住院时的血管活性药使用和机械通气情况，比较各组患者住院病死率、住EICU时间和住EICU费用等预后指标，使用秩相关检验SAC诊断标准和APACHE Ⅱ评分、CDS的相关性。结果各组患者的年龄、性别、基础疾病和住院期间使用机械通气方面差异无统计学意义（P>0.05）。无SAC、轻度SAC、中度SAC和重度SAC组APACHE Ⅱ评分分别为（14.3±2.8）、（15.6±2.5）、（19.2±2.1）和（22.3±3.5）。SAC严重程度越高，患者的APACHE Ⅱ评分及CDS越高（P<0.05），血管活性药物的使用越多（P<0.001），SAC与APACHE Ⅱ和CDS具有较高的相关性，相关系数分别为0.712和0.685（P<0.001），重度SAC患者具有更高的住院病死率（53.7%）、住EICU时间[(8.5±3.8)d]和EICU费用[(11.7±5.2)万元]。结论SAC与APACHE Ⅱ、CDS具有良好的相关性，SAC能在一定程度上预测脓毒症患者的病情严重程度和预后。
Abstract:
ObjectiveTo evaluate the value of diagnostic criteria of sepsisassociated coagulopathy (SAC) to predict the prognosis of patients with sepsis.MethodsThe clinical data of sepsis patients who were admitted to our emergency intensive care unit (EICU) from June 2014 to June 2017 were analyzed. The diagnosis of SAC was determined according to the international standardized ratio and platelet count at the time of admission. The patients were divided into four group (no SAC, mild SAC, moderate SAC and severe SAC). The age, gender, APACHE Ⅱ score, Chinese DIC scoring, underlying disease, vasoactive drug use and mechanical ventilation during hospitalization were recorded. The prognostic indicators such as hospital mortality, EICU stay time, and EICU cost were compared. The correlation with SAC diagnostic criteria and APACHE Ⅱ scores and CDS was determined using rank correlation.ResultsThere was no difference in age, gender, and underlying disease in each group（P>0.05）. APACHE Ⅱ scores of no SAC, mild SAC, moderate SAC and severe SAC group were (14.3±2.8), (15.6±2.5), (19.2±2.1), (22.3±3.5), respectively.The higher the severity of SAC, the higher the APACHE Ⅱand CDSscoreof the patient（P<0.05）, the more vasoactive drugs were used（P<0.001）. SAC had a high correlation with APACHE Ⅱ and CDSwith thecorrelation coefficients 0.712 and 0.685,respectively(P<0.001). Patients with severe SAC had a higher hospital mortality rate, EICU stay time, and EICU cost [53.7%, (8.5±3.8)daysand (11.7±5.2)million, respectively].ConclusionSAC has a good correlation with APACHE Ⅱ and CDS. SAC can predict the severity and prognosis of patients with sepsis.

参考文献/References:

[1]Graber ML, Patel M, Claypool S. Sepsis as a model for improving diagnosis[J]. Diagnosis, 2018, 5(1): 310.
[2]许丹.研究集束化治疗对综合ICU严重脓毒症患者预后的影响[J].当代医学，2018，24（33）：2123.
[3]Ziesmann MT, Marshall JC. Multiple Organ Dysfunction: The Defining Syndrome of Sepsis[J].Surg Infect (Larchmt), 2018, 19(2)：184190..
[4]Moore HB, Winfield RD, Aibiki M, et al. Is Coagulopathy an Appropriate Therapeutic Target During Critical Illness Such as Trauma or Sepsis?[J] Shock, 2017, 48(2): 159167.
[5]Levi M, van der Poll T. Coagulation and sepsis[J].Thromb Res, 2017, 149: 3844.
[6]Ranieri VM, Thompson BT, Barie PS, et al. Drotrecogin alfa (activated) in adults with septic shock[J].N Engl J Med, 2012, 366(22): 20552064.
[7]Yamakawa K, Aihrara M, Ogura H, et al. Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and metaanalysis[J].J Thromb Haemost, 2015, 13(4): 508519.
[8]Simmons J, Pittet JF. The coagulopathy of acute sepsis[J]. Curr Opin Anaesthesiol, 2015, 28(2): 227236.
[9]Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis3)[J]. JAMA, 2016, 315(8): 762774.
[10]中华医学会血液学分会血栓与止血学组. 弥散性血管内凝血诊断中国专家共识(2017年版)[J]. 中华血液学杂志, 2017, 38(5): 361363.
[11]林青伟，宋景春，曾庆波，等.大黄素对脓毒症大鼠凝血紊乱治疗的作用[J]. 东南国防医药, 2018,20 (5): 464470.
[12]Iba T, Di Nisio M, Thachil J, et al. Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity[J]. Crit Care, 2016, 20(1): 287.
[13]中华医学会急诊医学分会，中华危重病急救医学杂志编辑委员会，脓毒症并发弥散性血管内凝血诊治急诊专家共识专家组.脓毒症并发弥散性血管内凝血诊治急诊专家共识[J]. 实用检验医师杂志, 2017, 29(7): 129132.
[14]Iba T, Thachil J. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsisassociated disseminated intravascular coagulation: a perspective from Japan[J].Int J Hematol, 2016, 103(3): 253261.
[15]LeGall JR, Loirat P, Alpérovitch A. APACHE Ⅱa severity of disease classification system[J]. Crit Care Med, 1986, 14(8):754755.
[16]宋景春. 脓毒症合并弥散性血管内凝血的机制与监测[J]. 医学研究生学报, 2017, 30(7): 703708.
[17]Levi M. The Coagulant Response in Sepsis[J].Clin Chest Med, 2008, 29(4): 627642.
[18]Koyama K, Katayama S, Muronoi T, et al. Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis[J]. PLos One, 2018, 13(1): e0192064. doi: 10.1371/journal.pone.0192064.
[19]Tunjugutri RN, Mobegi FM, Cremers AJ, et al. PhageDerived Protein Induces Increased Platelet Activation and Is Associated with Mortality in Patients with Invasive Pneumococcal Disease[J]. mBio, 2017, 8(1). doi: 10.1128/mBio.0198416.
[20]孙建, 吴伟东. 脓毒症相关性血小板减少症的危险因素及预后分析[J]. 中华危重症医学杂志（电子版）, 2014, 7(3): 177181.

相似文献/References:

[1]张 丽,侯毅翰,张民伟,等.降钙素原在血流感染中的临床应用分析[J].医学研究与战创伤救治(原医学研究生学报),2013,15(06):603.[doi:10.3969/j.issn.1672-271X.2013.06.016]
　ZHANG Li,HOU Yi-han,ZHANG Min-wei,et al.Cost-effective analysis of procalcitonin in the diagnosis of bloodstream infection[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(2):603.[doi:10.3969/j.issn.1672-271X.2013.06.016]
[2]黄凤楼,刁孟元,钱海飞,等.降钙素原及内毒素对腹腔感染脓毒症患者预后的评估[J].医学研究与战创伤救治(原医学研究生学报),2014,16(02):147.[doi:10.3969/j.issn.1672-271X.2014.02.011]
　HUANG Feng-lou,DIAO Meng-yuan,QIAN Hai-fei,et al.Prognostic value of procalcitonin and endotoxin concentrations for intra-abdominal sepsis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(2):147.[doi:10.3969/j.issn.1672-271X.2014.02.011]
[3]刘 瑜,方 放,黄 方.糖皮质激素受体基因多态性与脓毒症临床转归的相关性研究[J].医学研究与战创伤救治(原医学研究生学报),2015,17(06):575.[doi:10.3969/j.issn.1672-271X.2015.06.005]
　LIU Yu,FANG Fang,HUANG Fang..Association of polymorphisms in glucocorticoid receptor with outcome of sepsis in a Chinese Han population[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(2):575.[doi:10.3969/j.issn.1672-271X.2015.06.005]
[4]郭剑,雷洁洁,章柏平,等.脓毒症患者连续性肾替代治疗时机选择及预后比较[J].医学研究与战创伤救治(原医学研究生学报),2018,20(01):37.[doi:10.3969/j.issn.1672-271X.2018.01.008]
　GUO Jian,LEI Jie-jie,ZHANG Bo-ping,et al.Comparison of timing and prognosis of continuous renal replacement therapy in patients with sepsis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(2):37.[doi:10.3969/j.issn.1672-271X.2018.01.008]
[5]窦燕,郭以河,孔晓飞,等.创伤弧菌脓毒症1例报道并文献复习[J].医学研究与战创伤救治(原医学研究生学报),2018,20(01):76.[doi:10.3969/j.issn.1672-271X.2018.01.018]
[6]李勇,宋薇.连续性血液净化联合益气活血法对脓毒症伴心肌功能障碍患者的临床疗效观察[J].医学研究与战创伤救治(原医学研究生学报),2018,20(03):225.[doi:10.3969/j.issn.1672-271X.2018.03.001]
　LI Yong,SONG Wei.The clinical efficacy of continuous blood purification combined with Yiqi Huoxue for the sepsis patients with myocardial dysfunction[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(2):225.[doi:10.3969/j.issn.1672-271X.2018.03.001]
[7]林青伟,宋景春,曾庆波,等.大黄素对脓毒症大鼠凝血紊乱治疗的作用[J].医学研究与战创伤救治(原医学研究生学报),2018,20(05):464.[doi:10.3969/j.issn.1672-271X.2018.05.004]
　LIN Qing-wei,SONG Jing-chun,ZENG Qing-bo,et al.Effect ofemodin on coagulation disorders of septic rats[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(2):464.[doi:10.3969/j.issn.1672-271X.2018.05.004]
[8]钟林翠,宋景春,姜峻,等.血小板聚集率在评价脓毒症患者血小板功能及预后中的价值[J].医学研究与战创伤救治(原医学研究生学报),2020,22(3):249.[doi:10.3969/j.issn.1672-271X.2020.03.006]
　ZHONG Lin-cui,SONG Jing-chun,JIANG Jun,et al.Clinical study on platelet aggregation to evaluate platelet function and prognosis in patients with sepsis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(2):249.[doi:10.3969/j.issn.1672-271X.2020.03.006]
[9]曾庆波,宋景春,钟林翠,等.严重创伤与脓毒症患者凝血功能紊乱的比较研究[J].医学研究与战创伤救治(原医学研究生学报),2020,22(4):367.[doi:10.3969/j.issn.1672-271X.2020.04.007]
　ZENG Qing-bo,SONG Jing-chun,ZHONG Lin-cui,et al.Comparation of coagulation dysfunction between severe trauma and sepsis patients[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(2):367.[doi:10.3969/j.issn.1672-271X.2020.04.007]
[10]陈慧敏,王立群,黄利民,等.降钙素原变化率对创伤后脓毒症患者抗生素合理使用的指导价值[J].医学研究与战创伤救治(原医学研究生学报),2020,22(4):408.[doi:10.3969/j.issn.1672-271X.2020.04.016]

备注/Memo

备注/Memo:
基金项目：南京市重点专科项目（2016010）
更新日期/Last Update: 2020-03-11